Associations between proinflammatory cytokines in the synovial fluid and radiographic grading and pain-related scores in 47 consecutive patients with osteoarthritis of the knee by Orita, Sumihisa et al.
RESEARCH ARTICLE Open Access
Associations between proinflammatory cytokines
in the synovial fluid and radiographic grading
and pain-related scores in 47 consecutive



















Background: One of the sources of knee pain in osteoarthritis (OA) is believed to be related to local chronic
inflammation of the knee joints, which involves the production of inflammatory cytokines such as tumor necrosis factor
alpha (TNFa), interleukin (IL)-6, and nerve growth factor (NGF) in the synovial membrane, and these cytokines are
believed to promote pathological OA. In the present study, correlations between proinflammatory cytokines in knee
synovial fluid and radiographic changes and functional scores and pain scores among OA patients were examined.
Methods: Synovial fluid was harvested from the knees of 47 consecutive OA patients, and the levels of TNFa, IL-6,
and NGF were measured using enzyme-linked immunosorbent assays. Osteoarthritic knees were classified using
Kellgren-Lawrence (KL) grading (1-4). The Western Ontario and McMaster University Osteoarthritis Index (WOMAC)
was used to assess self-reported physical function, pain, and stiffness.
Results: TNFa and IL-6 were detectable in knee synovial, whereas NGF was not. TNFa was not correlated with the
KL grade, whereas IL-6 had a significantly negative correlation. We observed differences in the correlations
between TNFa and IL-6 with WOMAC scores and their subscales (pain, stiffness, and physical function). TNFa
exhibited a significant correlation with the total score and its 3 subscales, whereas IL-6 exhibited a moderately
significant negative correlation only with the subscale of stiffness.
Conclusions: The present study demonstrated that the concentrations of proinflammatory cytokines are correlated
with KL grades and WOMAC scores in patients with knee OA. Although TNFa did not have a significant correlation
with the radiographic grading, it was significantly associated with the WOMAC score. IL-6 had a significant
negative correlation with the KL grading, whereas it had only a weakly significant correlation with the subscore of
stiffness. The results suggest that these cytokines play a role in the pathogenesis of synovitis in osteoarthritic knees
in different ways: TNFa is correlated with pain, whereas IL-6 is correlated with joint function.
Background
Knee osteoarthritis (OA) is a common chronic degen-
erative disease characterized by the loss of articular car-
tilage components due to an imbalance between
extracellular matrix destruction and repair [1]. The
entire joint structure is affected, including the synovial
membrane and subchondral bone, and OA can be
recognized as an irregularity and deformity of joint
spaces in radiographic images. Its main clinical sign is
joint pain, which not only contributes to functional lim-
itations and reduced quality of life but is also the lead-
ing cause of impaired mobility in the elderly population
[2]. Although the exact mechanism of knee pain in OA
is unclear, it is believed to be related to local chronic
inflammation of the knee joints, which involves the
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membrane, such as tumor necrosis factor alpha (TNFa),
interleukin (IL)-6, and nerve growth factor (NGF),
which are generally considered to promote pathological
OA [3-5]. Proinflammatory cytokine mediators have
been reported to contribute to OA pathogenesis by
increasing cartilage degradation and inducing hyperalge-
sia via a number of direct and indirect actions. TNFa
activates sensory neurons directly via its receptors and
initiates a cascade of inflammatory reactions via the pro-
duction of ILs [6,7]. IL-6 is reported to have a complex
role in OA pathogenesis by initiating inflammatory
responses such as the production of tissue inhibitors of
metalloproteinase, and this may act to limit cartilage
damage via negative feedback [8]. NGF is reportedly
upregulated in human osteoarthritic chondrocytes and
synovial fibroblasts, suggesting its important role in the
pathology of OA [6,9]. Another report indicated that
NGF antagonism is an important mediator of pain in
OA because its antagonistic effect resulted in analgesia
in a murine OA model [10].
Thus, investigations of the dynamic states of these
cytokines should be conducted. Additionally, a previous
study indicated a strong association between the radio-
graphic images of knees with OA and with knee pain
[11]. Under the hypothesis that relationships between
these cytokines and clinical evaluations in OA patients
are possible, the present study evaluated the association
between proinflammatory cytokines in the synovial fluid
from the knees of OA patients and radiographic severity
and pain scale scores.
Methods
Our Institutional Review Board approved the present
study. We obtained informed consent from each partici-
pating patient.
Patient selection
The present study included adult patients with knee
pain who visited our facility for clinical consultation
between August 2009 and March 2010. The present
study consisted of patients with knee OA diagnosed
using the American College of Rheumatology criteria for
OA who had not received any prior treatment. Patients
with clear clinical evidence of any involvement of
trauma, prior treatment, or other orthopedic diseases
including spinal disorders causing radicular pain in the
legs were excluded. Patients diagnosed with rheumatoid
arthritis based on physical examination and laboratory
data were also excluded.
Synovial fluid sampling and cytokine assay
With the approval of patients, samples of synovial joint
fluid were collected using a syringe and needle in our
outpatient clinics by experienced orthopedic physicians.
The samples of synovial fluid were aspirated directly
without lavage and immediately stored at -70°C until
use. Freeze-thaw cycles were avoided. Cytokine quantifi-
cation was performed using a double-antibody sandwich
enzyme-linked immunosorbent assay (ELISA) for TNFa,
IL-6 (R&D systems, Minneapolis, MN), and NGF (Bos-
ter Biological Tec., Wuhan, China) without dilution
according to the manufacturers’ protocols (centrifuga-
tion before use: for 15 min at 1,000 × g (TNFa and IL-
6) or for 20 min at 2,000 × g (NGF)). The detection lim-
i t so ft h ea s s a y sw e r e0 . 5p g / m lf o rT N F a,< 0 . 7 0p g / m l
for IL-6, and <1 pg/ml for NGF. All samples were
assessed in duplicate.
Grading of OA and pain evaluation
Anteroposterior radiographs of the symptomatic knees
were obtained. The X-ray beam was aimed at the lower
pole of the patella and kept parallel to the joint surface.
Radiographs were scored by experienced orthopedic sur-
geons using the Kellgren-Lawrence (KL) grading scale as
follows: grade 1, doubtful narrowing of joint space and
possible osteophytic lipping; grade 2, definite osteo-
phytes and possible narrowing of joint space; grade 3,
moderate multiple osteophytes, definite narrowing of
joints space, some sclerosis, and possible deformity of
bone contours; and grade 4, large osteophytes, marked
narrowing of joint space, severe sclerosis, and definite
d e f o r m i t yo fb o n ec o n t o u r s[ 1 2 ] .T h ef u n c t i o n a ls t a t u s
and pain level of each patient were evaluated using the
Western Ontario McMaster University Osteoarthritis
Index (WOMAC) score [13]. The index consists of 3
subscales: pain, stiffness, and physical function. A higher
score on the WOMAC scale represents poorer function
or greater pain. The data were arranged according to
the KL grade for each cytokine, and the correlations
between the cytokines were analyzed. Correlations
between the cytokine concentrations and WOMAC
score were also analyzed.
Statistical analysis
Statistical differences between the 2 groups were deter-
mined using the Mann-Whitney U test followed by Bon-
ferroni’s correction for multiple testing, and the
statistical significance among the groups was determined
using the Kruskal-Wallis test. The significance of corre-
lations was determined by Spearman’sr a n kc o r r e l a t i o n
test (PASW statistics ver. 18 (SPSS Inc (IBM), Somers,
NY)). A p value < 0.05 was considered significant.
Results
Patient demographics
Table 1 shows the patient demographics. Among the 50
patients enrolled in the present study, we could not
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osteoarthritic knees classified as KL grade 4, and thus,
we analyzed the other 47 samples. Disease duration
increased as the KL scores increased.
Concentrations of the proinflammatory cytokines
Figure 1 shows the concentrations of proinflammatory
cytokines in the synovial fluid of knee joints in relation
to the radiographic findings for these joints. Measurable
levels of TNFa and IL-6 were detected in all samples,
whereas NGF was not detectable in any of the samples
(CV value (%): TNFa, 5.8 ± 1.2; IL-6, 4.2 ± 0.18; NGF:
unable to be calculated).
The concentration of TNFa was significantly lower in
KL grades 2 to 4 than in KL grade 1 (KL 1, 6.5 ± 2.0
pg/ml (mean ± S.E.); KL 2, 3.6 ± 0.72 pg/ml (p =0 . 3 8
vs. KL 1); KL 3, 4.2 ± 0.48 pg/ml (p = 0.025 vs. KL 1);
and KL 4, 3.2 ± 0.86 pg/ml (p = 0.031 vs. KL 1)) (Figure
1A). The IL-6 concentration was significantly lower in
KL grades 3 and 4 than in KL grades 1 and 2 (KL 1,
401.6 ± 33.2 pg/ml; KL 2, 292.6 ± 42.2 pg/ml; KL 3,
162.9 ± 46.5 pg/ml; and KL 4, 78.6 ± 62.8 pg/ml) (p =
0.032 vs. KL 1; p = 0.036 vs. KL 2) (Figure 1B). NGF
was not detected in any sample.
Correlation between WOMAC score and cytokine
concentration
Figure 2 shows the correlations between the detectable
cytokines and the WOMAC score. Group A shows
TNFa, and group B shows IL-6. TNFa exhibited a mod-
erately significant positive correlation with the total
WOMAC score (A-1) and with each subscale (pain
(A-2), stiffness (A-3), and physical function (A-4) (p <
0.01)). IL-6 exhibited a moderately significant negative
correlation only with stiffness (B-3) (p < 0.05), whereas
it did not exhibit any significant correlation with the
other factors. The precise statistical values are shown in
Table 2.






No. of Patients 22 (21) 28 (26) 50 (47)
Average age
(years)
69.6 ± 7.3 69.8 ± 11.3 70.0 ± 2.1
KL grading
1 6 4 4.83 ± 2.0 10
2 6 9 14.8 ± 8.9 15
3 5 8 33.9 ± 18.6 13
4 5 (4)* 7 (5)* 45.3 ± 21.4 12 (9)*
*No fluid was obtained from 3 patients (1 man and 2 women), and thus, the
numbers in parenthesis indicate the effective numbers for the present study.
**Described as mean ± SEM.
(B) IL-6 (A) TNF_
*: P < 0.05 vs. K-L 1
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Figure 1 Concentrations of proinflammatory cytokines in the synovial fluid from the knee joints.( A )T h ec o n c e n t r a t i o no fT N F a
exhibited no significant correlation with KL grading, although there was a tendency for increased TNFa concentrations at lower KL grades. (B)
The concentration of IL-6 was significantly decreased in KL grades 3 and 4 compared with those in KL grades 1 and 2. NGF was undetectable in
all patient samples.
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Figure 2 Correlations between the detectable cytokines and the WOMAC score.G r o u pAs h o w sT N F a, and group B shows IL-6. TNFa
exhibited a moderately significant positive correlation with the total WOMAC score (A-1) and with the each subscale (pain (A-2), stiffness (A-3),
and physical function (A-4) (p < 0.01)). IL-6 exhibited a weakly significant negative correlation only with stiffness (B-3) (p < 0.05), whereas it
exhibited no correlation with the other subscales.
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The present study examined whether inflammation plays a
substantial role in the development of pain in OA. We
demonstrated that TNFa and IL-6 were detectable in the
synovial fluid sampled from the knees of OA patients,
whereas NGF was undetectable. TNFa was not correlated
with the KL grade, and IL-6 had a relatively significant
negative correlation with KL grading. Some differences
were found between TNFa and IL-6 regarding their corre-
lations with the WOMAC score and its subscales. TNFa
exhibited a moderately significant correlation with the
total score and its 3 subscales, whereas IL-6 exhibited a
weakly significant negative correlation with the subscale of
stiffness. The WOMAC scoring method used in the pre-
sent study was translated from the English version, and
thus, we believe that its validity is similar as that reported
in a previous study in Asian OA patients [14].
Evidence of proinflammatory cytokines in the synovial
fluid samples
The results of the present study are comparable with
those of previous studies, which using a zymosan-
induced mouse OA model, reported that TNFa is
related to synovitis and that IL-6 has a role in reducing
cartilage destruction [15-18]. These studies add impor-
tance to the present findings that TNFa inhibition may
improve the WOMAC score and that increased IL-6
activity in earlier phases of OA prevents cartilage
destruction. Brenner et al performed a similar experi-
ment using the synovial membranes and fluid from OA
patients, and reported that TNFa was undetectable in
their synovial fluid and that there were no correlations
between IL-6 levels and WOMAC pain subscores [19].
Regarding TNFa, some controversy exists among stu-
dies. Some previous studies reported low levels of TNFa
in the synovial fluid of OA patients [20-22], whereas
other studies including experiment models reported its
detection [23-25]. The present study detected TNFa in
the synovial fluid. These discrepancies may be attributa-
ble to the extremely low value of TNFa and the method
of collecting and processing synovial fluid. However, we
can suggest that TNFa is related to OA pathology and
clinical evaluations based on the present findings,
although additional investigations with greater numbers
of samples are needed. Additionally, TNFa was also
reported to not be regulated in the joints in late OA,
and this is consistent with the finding of the present
study [26].
As described in the Background section, NGF is con-
sidered an important factor in OA pathogenesis, and
thus, it is important to discuss why NGF was not
detected in the present study. We hypothesize that,
excluding any technical errors, NGF production is insuf-
ficient for detection in the synovial fluid obtained from
the knees of OA patients. According to a previous
report, the mRNA expression of neurotrophins includ-
ing NGF and its receptors was confirmed in the synovial
fluid and tissues of patients with OA, whereas NGF
mRNA expression was low [27]. Furthermore, NGF is a
basic protein, and this is disadvantageous for its exis-
tence in the relatively acidic milieu of the synovial fluid
[28]. Another study reported the diagnostic usefulness
of biopsied tissue as opposed to the use of synovial fluid
[26]. Thus, in addition to examining the synovial fluid,
it may be important to investigate NGF expression in
the subchondral tissue where inflammatory cytokines
are reported to be produced [29]. Moreover, to investi-
gate any correlation between proinflammatory cytokines
including NGF, multivariable analysis among these cyto-
kines should be performed in the future. Evaluating the
levels of these cytokines in the synovial fluid from com-
pletely normal knees is important but also difficult for
ethical reasons. Alternatively, we can evaluate the cyto-
kine levels in the synovial fluid from injured knees such
as those with anterior cruciate ligament (ACL) injuries;
however, the data may not be useful because proinflam-
matory cytokine levels are elevated in response to any
degradation or injury in the joint. However, we can
partly infer their levels from previous studies. One study
evaluating the cytokine levels in the knees of patients
with chronic ACL deficiencies reported that TNFa con-
centrations were lower in injured knees than in normal
knees, and the TNFa levels reported in that study were
also low compared with those in the present study [30].
Because IL-6 and TNFa levels are elevated in the early
p h a s eo fk n e ei n j u r i e s ,i tw ill be important to measure
their levels in normal knees.
Correlation between cytokine concentrations and KL
grading
A previous study indicated that the levels of TNFa in
the synovial fluid were positively correlated with Lar-
sen’s radiographic grading of bone destruction in rheu-
matoid arthritis patients, whereas no correlation
between the concentration of TNFa and Dahlgren’s
radiographic OA grade was found [31]. The report is
consistent with some of the results of the present study
regarding TNFa but not IL-6. The present study
revealed that TNFa is clearly not correlated with joint
Table 2 Statistical data of Figure 2
TNFa IL-6
rprp
Total 0.69 0.0023 -0.18 0.09
Pain 0.57 0.0069 -0.23 0.31
Stiffness 0.56 0.0054 -0.48 0.039
Physical function 0.64 0.0038 -0.16 0.89
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negatively correlated with KL grading, suggesting that
IL-6 has an important role in OA progression. Gener-
ally, members of the IL family are reported to be related
to the severity of cartilage destruction [32,33] The pre-
sent study indicated that IL-6 production might be
increased in the early stage of joint destruction in OA
patients. Other studies have reported that TNFa induces
IL-6 upregulation, and thus, IL-6 may still be correlated
with OA progression [34-36]. Increased IL-6 activity has
been reported to be associated with increased proteogly-
can synthesis in articular cartilage in dogs with experi-
mental ACL transaction [24], and thus, IL-6 production
is highest in the early stages of joint injury.
Considering these reports, IL-6 may be related to the
formal pathogenesis of OA, suggesting that active carti-
lage destruction occurs at the greatest rate in earlier KL
grades. In other words, late-stage KL grading may indi-
cate the “burnt ruins” acquired after active inflammation
where IL-6 is more directly involved than TNFa.
Correlation between cytokine concentrations and the
WOMAC score
The present study demonstrated that TNFa is signifi-
cantly correlated with the WOMAC score including the
subscores. However, IL-6 was not correlated with the
WOMAC score excluding the subscore of stiffness,
which indicates that IL-6 primarily affects the progress
of the degeneration of joint cartilage in OA that leads to
joint stiffness.
Furthermore, we found a correlation only with the sub-
score of stiffness, which can be derived from the con-
structive degradation of the cartilage, and we found no
correlation with the subscore of pain. A previous paper
reported a negative correlation between IL-6 activity and
radiographic OA scoring in dog OA models [20], and
this coincides with the results of the present study.
The present study has some limitations. First, we did
not examine the gene expression of each cytokine. Var-
iations in several genes that regulate inflammation have
been reported to be associated with the differential
expression of inflammatory mediators [37-39], some of
which have been associated with OA pathology [40-44].
Thus, further studies including genetic investigations are
needed, particularly for NGF. Second, the obscurity of
KL grading, which is based on an unclear definition of
t h ej o i n ts p a c ef i n d i n g s ,c o uld have affected the results
of the present study. Precise evaluation using more
quantified grading systems such as the OARSI atlas
should be performed in future studies. Third, we could
not examine normal knees because it may be technically
difficult and ethically improper to obtain control syno-
vial fluid from intact knee joints. We should evaluate
knees with other injuries or degradations in future
studies. Last, we only examined the synovial fluid. It will
be important to assess the serum levels of these cyto-
kines and compare them with both the levels of cyto-
kines in the synovial fluid and the grading scores.
Conclusions
The present study demonstrated that the concentrations
of proinflammatory cytokines can be correlated with the
KL grades and WOMAC scores of knee OA patients.
TNFa did not have a significant correlation with the
radiographic grading, while it did with the WOMAC
scoring. IL-6 had a significant negative correlation with
K Lg r a d i n g ,a n do n l yaw e a k l ys i g n i f i c a n tc o r r e l a t i o n
with the subscore of stiffness. These 2 cytokines were
moderately correlated, and the results suggest that these
cytokines play a role in the pathogenesis of synovitis in
osteoarthritic knees in different ways. TNFa is corre-
lated with pain, whereas IL-6 is correlated with joint
function. NGF was undetectable in the synovial fluid,
illustrating the need for differently designed experiments
in future studies.
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